mittyri
★★  

Russia,
2022-12-07 16:51
(60 d 12:10 ago)

Posting: # 23386
Views: 611
 

 PKanalix validation [Software]

Dear All,

I missed this abstract published during PAGE meeting: Validation of non-compartmental analysis (NCA) and bioequivalence results of PKanalix with respect to Phoenix WinNonLin and SAS.

Most interesting here is the set of the datasets they are using:

References:
[1] Schütz et al. “Reference Datasets for 2-Treatment , 2-Sequence , 2-Period Bioequivalence Studies.”, AAPS J. 16, 1292–1297 (2014).
[2] Fuglsang et al. “Reference Datasets for Bioequivalence Trials in a Two-Group Parallel Design.”, AAPS J. 17, 400–404 (2015).


Looks like that sets become to be state of the art! :-D

Kind regards,
Mittyri
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2022-12-08 10:46
(59 d 18:16 ago)

@ mittyri
Posting: # 23391
Views: 446
 

 PKanalix validation

Hi Mittyri,

❝ Looks like that sets become to be state of the art! :-D


Makes sense. Currently replicate designs for reference-scaling are not implemented in PKanalix. Lixoft is working on it.
At the “Spring School with PKanalix™” (March 22–24, 2022) Lixoft pointed out that the paper of the usual suspects (doi:10.1208/s12248-020-0427-6) will be used in validation. ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
22,479 posts in 4,709 threads, 1,603 registered users;
20 visitors (0 registered, 20 guests [including 12 identified bots]).
Forum time: 05:02 CET (Europe/Vienna)

The rise of biometry in this 20th century,
like that of geometry in the 3rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding.    R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5